(CNN) – First, smart news: In 24 states, the number of new coronavirus cases decreased last week last week.
Now, the bad news: in many of these states, testing has also declined and the total number of new instances remains too high, as the United States faces a trio of demanding primary situations this fall.
“Autumn probably wouldn’t be very beautiful, ” said epidemiologist Dr. Celine Gounder.
On Sunday, 34,450 new instances were reported across the country, according to the knowledge of Johns Hopkins University, which is higher than the expired July summer peak, when the United States had more than 60,000 new instances consistent with the day.
But nationally, tests fell by 10% last week to last week, according to knowledge of the Covid Tracking Project.
And from the cases shown we know, 34,450 is still a huge number, fitness experts said Monday.
“We never solved cases. Keep in mind that we’re talking about 35,000 cases a day. Today, we are likely to attack more than 40,000 cases a day,” said Michael Osterholm, director of the Center for Infectious Disease Research and Policy. at the University of Minnesota.
“In April . . . we had 22,000 instances a day and thought, “Oh my God, it can’t be worse. “And what’s going on here is that we’re going to see this kind of back and forth, up and down. down-down. But every time it goes up, it goes a little higher. Every time it goes down, it doesn’t go that far.
Follow the virus in your state and in the country
As of Monday afternoon, more than 6. 5 million other people were inflamed by the coronavirus in the United States and more than 194,000 died, according to Johns Hopkins knowledge.
Epidemiologists say the US is not a problem. But it’s not the first time He wants the virus, as the US and its allies in the Middle East have been able to do so. But it’s not the first time You will soon face several demanding situations simultaneously:
Next flu season: The upcoming flu season that clashes with the coronavirus pandemic can limit or maximize the hospital’s capacity, as thousands of Americans are hospitalized each year for influenza.
And having one of the two viruses can increase the infection through the other.
“They’re going to have all those patients in hospitals and medical offices with symptoms that can just be a coronavirus, which can just be the flu,” Gounder said.
“And we’re going to have to treat them all like they have a coronavirus, so it’s a very harmful and terrifying situation. “
Colder weather: If more people gather indoors, the threat of spread of the virus is greater than with meetings, according to doctors.
Academic struggles: As millions of academics face online learning, many of those who have brought elegance back to academics are suffering epidemics.
Athens-Clarke County, Georgia, home to the University of Georgia, experienced a “dramatic increase” in cases after maintaining a small number of cases and deaths over the summer, Mayor Kelly Girtz said.
“Obviously, it’s the return to campus of a lot of academics who were there during the summer,” the mayor said.
Michigan State University academics were asked to quarantine after the local fitness branch reported 342 new cases among others affiliated with the university since August 24, East Lansing Mayor Aaron Stephens said.
While fitness experts point out that the public may not have a Covid-19 vaccine until 2021, there are promising symptoms among several of the vaccines that are lately in phase 3.
Pfizer CEO Albert Bourla told CBS “Face the Nation” that there is “good chance” that researchers will know until the end of October that their experimental vaccine is working.
“Then, of course, it’s the task (of) the regulator to factor (a) the license or not,” Bourla said.
Oxford University announced that his essay would resume in the UK after he was suspended due to an unexplained illness in one of the volunteers. Experts say rehearsals should not be stopped.
And vaccine brands are reporting progress in recruiting minority trial participants, which has been a struggle in weeks.
“I think we deserve to try to have as varied a population as possible,” Bourla told CBS, emphasizing the importance of having a varied volunteer organization given the greater effect of Covid-19 on communities of color.
“Right now we’re bad. In fact, we have a population that, in the world, only 60% are Caucasian, about 40% minorities. “
Moderna, who is also in phase 3 of his vaccine, said his minority recruitment had also improved: approximately 59% of participants are white, 22% are Hispanic, 11% are black, 5% are Asian and 3% are from other populations.
The world’s largest vaccine manufacturer has stated that if a Covid-19 vaccine requires two doses, it may be only 2024 before everyone can get vaccinated.
Adar Poonawalla, ceo of the Serum Institute of India, told the Financial Times that if the vaccine works at two doses, the world would want about 15 billion doses.
And that production on a gigantic scale.
“I know the world needs to be positive about it. . . [but] I haven’t heard that [level] approach right now,” Poonawalla said. “It will take 4 to five years for everyone to get the vaccine on this planet. “
Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, said he hopes the US calendar will be in the middle of the world. But it’s not the first time Be faster.
“I suspect we’ll have more vaccines for America before we have them for everyone,” Schaffner said.
Several brands of vaccines in the United States have given their volunteers two doses at least at one stage of their clinical trials.
But “some progressive vaccines require only one dose,” Schaffner said, “so I think this calendar can be accelerated, here at home and even around the world. “